TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7802271

Group type: EXPERIMENTAL
Intervention: Postoperative oxygen saturation monitoring in 19 children
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Postoperative oxygen saturation monitoring in 50 children
Number of subjects: 69

Group type: COMPARATOR
Intervention: Comparison of monitored time with oxygen saturation less than 95%, 90%, 85%, or 80%
Number of subjects: 69
Study: 2180328

Group type: EXPERIMENTAL
Intervention: Antidepressants or placebo (3-6 weeks treatment)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 112
Study: 380269

Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 48
Study: 6345340

Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 48
Study: 29475774

Group type: EXPERIMENTAL
Intervention: DAO enzyme supplementation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 29703182

Group type: EXPERIMENTAL
Intervention: Warning label with 'damages your health' (without 'can')
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Warning label with 'causes cancer'
Number of subjects: 619

Group type: COMPARATOR
Intervention: Control group receiving no warning label
Number of subjects: 619
Study: 27322802

Group type: EXPERIMENTAL
Intervention: Heavy drinking confederate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light drinking confederate
Number of subjects: 0

Group type: COMPARATOR
Intervention: No (alcohol) drinking confederate
Number of subjects: 0
Study: 24875804

Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 0
Study: 22959457

Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (IMP) 25-50 mg/d
Number of subjects: 738

Group type: COMPARATOR
Intervention: 8% Crinone vaginal gel
Number of subjects: 738
Study: 20492837

Group type: EXPERIMENTAL
Intervention: OROS-MPH (titrated to 72 mg/d)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 255
Study: 18541000

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice-daily
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg twice-daily
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Apixaban 20 mg once-daily
Number of subjects: 520

Group type: COMPARATOR
Intervention: LMWH followed by VKA
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Apixaban (all groups combined)
Number of subjects: 520

Group type: COMPARATOR
Intervention: LMWH/VKA (control group)
Number of subjects: 520
Study: 14998812

Group type: EXPERIMENTAL
Intervention: Signs of Suicide (SOS) prevention program
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2100
Study: 11220454

Group type: EXPERIMENTAL
Intervention: Electrophysiologic testing (EP)‐guided therapy with implantable defibrillator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrophysiologic testing (EP)
Number of subjects: 0
Study: 8994421

Group type: EXPERIMENTAL
Intervention: Direct NO donors (infusion of linsidomine followed by oral molsidomine)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Oral diltiazem
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Combined major clinical events (death, nonfatal myocardial infarction, and coronary revascularization)
Number of subjects: 700
Study: 7971288

Group type: EXPERIMENTAL
Intervention: Dual-energy x-ray absorptiometry (DXA) of the spine
Number of subjects: 556

Group type: COMPARATOR
Intervention: Peripheral quantitative computed tomography (pQCT) of the distal radius
Number of subjects: 556
Study: 3674276

Group type: EXPERIMENTAL
Intervention: Hand-held weights
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-hand-held weights
Number of subjects: 28
Study: 30396627

Group type: EXPERIMENTAL
Intervention: Cinnamon (1000 mg capsules)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (1000 mg starch capsules)
Number of subjects: 0
Study: 27276811

Group type: EXPERIMENTAL
Intervention: Spinal dural release during expansive cervical laminoplasty (group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Simple expansive cervical laminoplasty (group B)
Number of subjects: 32
Study: 24798208

Group type: EXPERIMENTAL
Intervention: Arousing interest through an invitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arousing interest on the website itself
Number of subjects: 0
Study: 22196836

Group type: EXPERIMENTAL
Intervention: Cognitive therapy intervention (brief, nurse-delivered during hospitalization with a 1-week booster phone call)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 20200201

Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 10544
Study: 17623604

Group type: EXPERIMENTAL
Intervention: Computer-assisted TKA
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 52
Study: 16360063

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Biventricular (BiV) pacing
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing with ventricular fusion
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing without fusion
Number of subjects: 34
Study: 12608624

Group type: EXPERIMENTAL
Intervention: Inhaled anesthetics and/or radiation exposure
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (matched for maternal age and gestational age)
Number of subjects: 95
Study: 9649457

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg AM and 20 mg PM) for 7 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 7978090

Group type: EXPERIMENTAL
Intervention: Fenfluramine (60‐mg oral dose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (12 healthy males)
Number of subjects: 19
Study: 3263508

Group type: EXPERIMENTAL
Intervention: IL-2 at 1 X 10(6) U/m2 per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-2 at 3 X 10(6) U/m2 per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous-infusion IL-2 at 3 X 10(6) U/m2 per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined regimen (bolus and continuous IL-2) at 3 X 10(6) U/m2 per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin added to IL-2 regimen
Number of subjects: 0
Study: 31126554

Group type: EXPERIMENTAL
Intervention: Tung's acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cyproterone acetate/ethinylestradiol (CPA/EE)
Number of subjects: 60
Study: 27861459

Group type: COMPARATOR
Intervention: Waiting Group (WG; n = 16)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Direct Group (DG; n = 17)
Number of subjects: 33
Study: 27187105

Group type: EXPERIMENTAL
Intervention: IPC (ischemia cycles lasted 5 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SHAM (ischemia cycles lasted 1 min)
Number of subjects: 30
Study: 24411642

Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (typically developing students)
Number of subjects: 55
Study: 22801017

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Tsang‐Erh‐San extract granules and Houttuynia extract powder)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 53
Study: 19351979

Group type: EXPERIMENTAL
Intervention: Regularized B-spline deformable registration for respiratory gated PET images
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motion correction using the registration algorithm
Number of subjects: 0
Study: 17549956

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 20
Study: 15295372

Group type: EXPERIMENTAL
Intervention: Fetal fibronectin results available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fetal fibronectin results not available
Number of subjects: 0
Study: 11341338

Group type: EXPERIMENTAL
Intervention: HRT + PTH(1-34) 400 U (25 microg) per day for 3 years
Number of subjects: 52

Group type: COMPARATOR
Intervention: HRT alone
Number of subjects: 52
Study: 9626828

Group type: EXPERIMENTAL
Intervention: Rescue PTCA
Number of subjects: 198

Group type: COMPARATOR
Intervention: Conservative management after failed thrombolysis
Number of subjects: 198

Group type: COMPARATOR
Intervention: Successful thrombolysis
Number of subjects: 198
Study: 7615228

Group type: EXPERIMENTAL
Intervention: Sodium phosphate-bisacodyl
Number of subjects: 147

Group type: COMPARATOR
Intervention: PEG-ES lavage
Number of subjects: 147
Study: 2197450

Group type: EXPERIMENTAL
Intervention: Postcoital trimethoprim-sulfamethoxazole
Number of subjects: 27

Group type: COMPARATOR
Intervention: Postcoital placebo
Number of subjects: 27
Study: 955230

Group type: EXPERIMENTAL
Intervention: Full-strength dimethylsulfoxide (DMSO) and potent topical corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower strengths of DMSO
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 31217178

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) diclofenac (75 mg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oral (PO) diclofenac (100 mg)
Number of subjects: 300
Study: 26685923

Group type: EXPERIMENTAL
Intervention: Yoga and compassion meditation program (n=25), 8 weeks duration, 3 sessions per week, each lasting 1 hour and 15 minutes.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (CG) (n=21), received no treatment.
Number of subjects: 46
Study: 25882029

Group type: EXPERIMENTAL
Intervention: On-stimulation period (DBS active)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Off-stimulation period (DBS inactive)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison of on-stimulation vs off-stimulation
Number of subjects: 15
Study: 23377231

Group type: EXPERIMENTAL
Intervention: Bilateral movement therapy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Unilateral movement therapy
Number of subjects: 10
Study: 21952008

Group type: EXPERIMENTAL
Intervention: Metronidazole (10-day regimen: 2 days prior to surgery and 7 days following)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Regular preoperative chemoprophylaxis (Control group)
Number of subjects: 70
Study: 19656689

Group type: EXPERIMENTAL
Intervention: Topical application of 2.5% w/w Reseda luteola extract (s-RE)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 1% w/w
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle (glycerol)
Number of subjects: 50
Study: 17403977

Group type: EXPERIMENTAL
Intervention: Low doses of olanzapine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High doses of olanzapine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low doses of risperidone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High doses of risperidone
Number of subjects: 12
Study: 15526817

Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg plus formoterol 4.5 microg
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Budesonide 100 microg plus formoterol 4.5 microg
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Budesonide 200 microg alone
Number of subjects: 1272
Study: 11298132

Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine (ZDV-3TC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No antiretroviral treatment
Number of subjects: 70
Study: 9760814

Group type: COMPARATOR
Intervention: MCP-1 levels in urine
Number of subjects: 34

Group type: COMPARATOR
Intervention: MCP-1 levels in serum
Number of subjects: 34
Study: 1322780

Group type: EXPERIMENTAL
Intervention: Dexamethasone iontophoresis (E)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo iontophoresis (P)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (C)
Number of subjects: 18
Study: 6733173

Group type: EXPERIMENTAL
Intervention: Bilateral ECT
Number of subjects: 28

Group type: COMPARATOR
Intervention: Unilateral ECT
Number of subjects: 28
Study: 31059991

Group type: EXPERIMENTAL
Intervention: H1-coil
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 8-coil
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control (standard-of-care pharmacotherapy alone)
Number of subjects: 228
Study: 30566472

Group type: COMPARATOR
Intervention: Four-part intervention targeting routine work practices, department conditions, and faculty readiness over an 18-month period.
Number of subjects: 0
Study: 27568890

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in noninvasive ventilation group
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in continuous positive airway pressure group
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in lifestyle modification group
Number of subjects: 302

Group type: COMPARATOR
Intervention: Supplemental oxygen across all groups
Number of subjects: 302
Study: 23328710

Group type: EXPERIMENTAL
Intervention: Cinacalcet with low-dose active vitamin D
Number of subjects: 309

Group type: COMPARATOR
Intervention: Usual care without cinacalcet (Control)
Number of subjects: 309
Study: 21193852

Group type: EXPERIMENTAL
Intervention: 14-week weight control intervention delivered by classroom teachers
Number of subjects: 618

Group type: COMPARATOR
Intervention: General health intervention (Control)
Number of subjects: 618
Study: 19486273

Group type: EXPERIMENTAL
Intervention: Melatonin treatment (daily use in 65% of children, occasional use in 12%)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Discontinuation of melatonin treatment
Number of subjects: 94
Study: 17728213

Group type: EXPERIMENTAL
Intervention: cagA-positive H. pylori infection
Number of subjects: 2145

Group type: EXPERIMENTAL
Intervention: cagA-negative H. pylori infection
Number of subjects: 2145

Group type: COMPARATOR
Intervention: Individuals with normal mucosa or superficial gastritis (control)
Number of subjects: 2145
Study: 15271128

Group type: EXPERIMENTAL
Intervention: Timed Up and Go test
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Step test
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Functional Reach test
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Lateral reach test
Number of subjects: 456
Study: 11842864

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (1200 mg) and glucosamine hydrochloride (1500 mg) daily for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 7640143

Group type: EXPERIMENTAL
Intervention: Tucaresol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2767021

Group type: EXPERIMENTAL
Intervention: 6-month home-based aerobic exercise training program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 120
Study: 340133

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 19

Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 19
Study: 31918169

Group type: EXPERIMENTAL
Intervention: Working memory intervention
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Mindfulness training intervention
Number of subjects: 93

Group type: COMPARATOR
Intervention: Wellness-focused control condition
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Working memory and distress tolerance
Number of subjects: 93
Study: 31062834

Group type: EXPERIMENTAL
Intervention: Vortioxetine, 15 mg/day (n=36)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Other common antidepressants (n=72)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Other common antidepressants
Number of subjects: 108
Study: 28801386

Group type: EXPERIMENTAL
Intervention: Integrated Management of Neonatal and Childhood Illness programme
Number of subjects: 60480
Study: 25460261

Group type: EXPERIMENTAL
Intervention: Restorative Safety Behaviors (RSB)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Preventive Safety Behaviors (PSB)
Number of subjects: 67

Group type: COMPARATOR
Intervention: No Safety Behaviors (NSB)
Number of subjects: 67
Study: 23728991

Group type: EXPERIMENTAL
Intervention: Health education requests regarding emotional distress
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Health education requests regarding rehabilitation
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Health education requests regarding disease symptoms
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Health education requests regarding nutritional support
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Health education requests regarding sexual health
Number of subjects: 374
Study: 21560476

Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (CD34+ selected cells)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (all mononuclear cells)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (both CD34+ selected cells and all mononuclear cells)
Number of subjects: 0
Study: 19702080

Group type: EXPERIMENTAL
Intervention: Lixu Jieyu Recipe (LJR), 100 mL twice a day for 3 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: Vitamin B tablets (10 mg twice a day), adenosine triphosphate (ATP, 20 mg thrice a day), and Oryzanol tablets (20 mg thrice a day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lixu Jieyu Recipe (LJR)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (Vitamin B, ATP, Oryzanol)
Number of subjects: 75
Study: 16814691

Group type: EXPERIMENTAL
Intervention: Multiple Random Staircase (MRS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Tender point count
Number of subjects: 65

Group type: COMPARATOR
Intervention: Dolorimetry
Number of subjects: 65
Study: 12919762

Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin combined with octenidine dihydrochloride bodywash over a period of five days
Number of subjects: 32
Study: 10700487

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 60
Study: 9061154

Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention (two warmed thermal blankets and a hospital bedspread)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention plus a reflective blanket
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention plus a reflective blanket and a reflective head covering
Number of subjects: 0
Study: 8202722

Group type: COMPARATOR
Intervention: rHuEPO 100 U/kg subcutaneously three times per week for up to 8 weeks
Number of subjects: 413

Group type: COMPARATOR
Intervention: rHuEPO 150 U/kg subcutaneously three times per week for 12 weeks
Number of subjects: 413

Group type: COMPARATOR
Intervention: rHuEPO treatment in responding patients
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: rHuEPO therapy overall
Number of subjects: 413
Study: 3223250

Group type: EXPERIMENTAL
Intervention: Adeno‐tonsillectomy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Neither procedure (Control)
Number of subjects: 150
Study: 31735996

Group type: EXPERIMENTAL
Intervention: Upper limb pure eccentric training for 6 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: No additional exercise during 6 weeks
Number of subjects: 21
Study: 30278335

Group type: EXPERIMENTAL
Intervention: Feed-forward on drafts
Number of subjects: 118

Group type: COMPARATOR
Intervention: Feed-forward on outlines
Number of subjects: 118
Study: 28608311

Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg administered 24 hours before and immediately before the procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered 24 hours before and immediately before the procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg
Number of subjects: 0
Study: 26272499

Group type: EXPERIMENTAL
Intervention: Agenda form
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 23808786

Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 32

Group type: COMPARATOR
Intervention: Neurofeedback (NF)
Number of subjects: 32
Study: 21258075

Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg bolus followed by an infusion of 0.2 µg kg(‐1) min(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19797993

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breathing 14.1% oxygen (hypoxia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breathing air (normoxia)
Number of subjects: 0
Study: 16799350

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: TIVA (Total Intravenous Anesthesia with Propofol)
Number of subjects: 20
Study: 12559648

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data monitoring board
Number of subjects: 0
Study: 10887047

Group type: EXPERIMENTAL
Intervention: Activated Charcoal (7.5 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated Charcoal (15 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diethylcarbamazine (150 mg)
Number of subjects: 6
Study: 9326758

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 8
Study: 8397726

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyric acid (GHB) 25 mg/kg orally
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyric acid (GHB) in an open study every 2 to 4 hours for the first 2 days and 4 to 6 hours for the following 6 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: GHB treatment suspended after 8 days
Number of subjects: 27
Study: 4091067

Group type: EXPERIMENTAL
Intervention: 8 ppm target CO, $5 per day incentive (n = 11)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 16 ppm target CO, $4 per day incentive (n = 8)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 8 ppm target CO, no incentive (n = 9)
Number of subjects: 28
Study: 31197218

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 50,000 IU/month
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 75,000 IU/month
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 IU/month
Number of subjects: 48